04/24/2026
Focal Segmental Glomerulosclerosis (FSGS) is a rare kidney disease that affects the kidney’s filtering units, which can lead to protein loss in the urine and reduced kidney function over time. Researchers are studying FSGS to better understand the condition and explore potential treatment options through clinical research.
Research by Design is screening participants for a clinical study for participants with focal segmental glomerulosclerosis (FSGS). If you have FSGS confirmed by recent kidney biopsy, contact us to schedule a paid screening today. If you screen and we determine you are eligible to participate, you can earn up to $1400 to participate in our clinical study for FSGS.